IDO1 and B-cell chronic lymphocytic leukemia: As we observed enhanced expression of IDO1 in tumor-associated myeloid cells in the Eμ-TCL1 mouse model of CLL, we aimed at testing the potential of therapeutically targeting IDO1 in this model.